NIR‐II‐Responsive Carbon Dot/Bi 2 S 3 Enables Mild Hyperthermia‐Amplified Sonocatalytic Therapy Through Heterojunctions Engineering
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.71768 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Nan Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Senior Department of Obstetrics and Gynecology, Chinese PLA General Hospital, Beijing, China. Hauptthemen laut MEDLINE: Carbon Quantum Dots, Hyperthermia, Induced, Sulfides, Ultrasonic Therapy. Die Arbeit nennt 74 Literaturangaben. Gefördert von: Science and Technology Commission of Shanghai Municipality.
Abstract (Originalsprache)
Sonodynamic therapy (SDT) demonstrates significant promise for noninvasive therapy of deep solid tumors such as cervical cancer, but its therapeutic efficacy is greatly restricted by low‐efficiency sonosensitizers and the immunosuppressive tumor microenvironment (TME). Herein, we report the development of a novel Type‐II carbon dot (CD)/Bi 2 S 3 heterojunction for the mild NIR‐II photothermal therapy (mPTT) amplified SDT/nanocatalytic therapy (NCT). The formation of heterojunctions drives the spatial separation of electron–hole pairs under ultrasound excitation, amplifying the generation of reactive oxygen species (ROS) while simultaneously utilizing highly oxidized holes to consume overexpressed GSH. In addition, under 1064 nm laser irradiation, the mild NIR‐II photothermal effect generated by CD/Bi 2 S 3 heterojunctions acts as a powerful thermodynamic accelerator, which not only enhances the intrinsic peroxidase (POD) and catalase (CAT) activities, but also relieves hypoxic TME. Based on the cascade amplification of ROS generation and reversal of immunosuppressive TME, CD/Bi 2 S 3 heterojunctions not only achieve high‐efficiency tumor eradication but also facilitate the infiltration of T cells in combination with PD‐L1 inhibitors, successfully triggering a strong systemic antitumor immune response and inducing persistent immune memory. This work presents an innovative strategy for designing efficient heterojunction nanoplatforms that integrate mild NIR‐II PTT, SDT, NCT, and TME regulation functions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Senior Department of Obstetrics and Gynecology, Chinese PLA General Hospital, Beijing, China.
- Department of Obstetrics and Gynecology, the First Medical Center, Chinese PLA General Hospital, Beijing, China.
- Department of General Surgery, the First Medical Center, Chinese PLA General Hospital, Beijing, China.
- Medical School of Chinese PLA, Beijing, China.
- School of Environmental and Chemical Engineering, Shanghai University, Shanghai, China.
- Department of Obstetrics and Gynecology, General Hospital of Central Theater Command, Wuhan, Hubei, China.
ORCID-Profile: Can Yang, Jinyan Hu, Bijiang Geng
Förderung
- Science and Technology Commission of Shanghai Municipality
Zitieren
APA
Wang, N., Zou, G., Zhang, N., Yang, C., Zhao, Z., Hu, J., Zhao, Y., Geng, B., Yang, S., & Li, L. (2026). NIR‐II‐Responsive Carbon Dot/Bi 2 S 3 Enables Mild Hyperthermia‐Amplified Sonocatalytic Therapy Through Heterojunctions Engineering. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71768
Vancouver
Wang N, Zou G, Zhang N, Yang C, Zhao Z, Hu J, et al. NIR‐II‐Responsive Carbon Dot/Bi 2 S 3 Enables Mild Hyperthermia‐Amplified Sonocatalytic Therapy Through Heterojunctions Engineering. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.71768
BibTeX
@article{Wang2026,
author = {Wang, Nan and Zou, Guijun and Zhang, Nina and Yang, Can and Zhao, Zhihao and Hu, Jinyan and Zhao, Yan and Geng, Bijiang and Yang, Saihua and Li, Lian},
title = {NIR‐II‐Responsive Carbon Dot/Bi 2 S 3 Enables Mild Hyperthermia‐Amplified Sonocatalytic Therapy Through Heterojunctions Engineering},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.71768}
}
EUVIMED